Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment.
Cabrero-de Las Heras S, Hernández-Yagüe X, González A, Losa F, Soler G, Bugés C, Baraibar I, Esteve A, Pardo-Cea MÁ, Ree AH, Martínez-Bosch N, Nieva M, Musulén E, Meltzer S, Lobato T, Vendrell-Ayats C, Queralt C, Navarro P, Montagut C, Grau-Leal F, Camacho D, Legido R, Mulet-Margalef N, Martínez-Balibrea E.
Cabrero-de Las Heras S, et al. Among authors: buges c.
Biomed Pharmacother. 2024 Jul;176:116857. doi: 10.1016/j.biopha.2024.116857. Epub 2024 Jun 7.
Biomed Pharmacother. 2024.
PMID: 38850664
Free article.